Literature DB >> 10334594

Molecular typing of Legionella pneumophila serogroup 1 by pulsed-field gel electrophoresis with SfiI and comparison of this method with restriction fragment-length polymorphism analysis.

A S DE Zoysa, T G Harrison.   

Abstract

A panel of 131 well-characterised Legionella pneumophila serogroup 1 strains, previously used to evaluate a restriction fragment-length polymorphisms (RFLP) typing scheme, was examined by pulsed-field gel electrophoresis (PFGE) with the restriction endonuclease SfiI. The data obtained show that PFGE with SfiI is a highly discriminatory method yielding an index of discrimination (IOD) of 0.992 and 0.975, with 100% and 90% similarity thresholds respectively, compared with an IOD of 0.909 for the RFLP typing method. Reproducibility of PFGE profiles within gels was excellent and it was possible to compare the profiles visually. However, the reproducibility of the technique between gels was poor and visual comparison of the patterns was extremely difficult. Computer-aided analysis assisted the assessment of inter-gel reproducibility. Of 11 duplicates examined only four pairs showed 100% similarity, although 9 of 11 showed > or =90% similarity. In an attempt to determine if the PFGE banding patterns were sufficiently unambiguous to allow the method to be used as a definitive typing method, 20 coded strains were examined. At a 90% similarity level, 16 of these were placed in the correct PFGE type and four were not allocated to a type. Partial digestion of DNA by SfiI was noted despite careful control of DNA and enzyme concentrations, suggesting that an alternative enzyme might give more reproducible results.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334594     DOI: 10.1099/00222615-48-3-269

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  A hospital-associated outbreak of Legionnaires' disease caused by Legionella pneumophila serogroup 1 is characterized by stable genetic fingerprinting but variable monoclonal antibody patterns.

Authors:  Sverker Bernander; Kerstin Jacobson; Jürgen Herbert Helbig; Paul Christian Lück; Monica Lundholm
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

2.  Optimization of pulsed-field gel electrophoresis for Legionella pneumophila subtyping.

Authors:  Haijian Zhou; Hongyu Ren; Bingqing Zhu; Biao Kan; Jianguo Xu; Zhujun Shao
Journal:  Appl Environ Microbiol       Date:  2010-01-08       Impact factor: 4.792

3.  Characterization of a tandem repeat polymorphism in Legionella pneumophila and its use for genotyping.

Authors:  C Pourcel; Y Vidgop; F Ramisse; G Vergnaud; C Tram
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

4.  Legionella pneumophila serogroup 1 strain Paris: endemic distribution throughout France.

Authors:  Helena Aurell; Jerome Etienne; Françoise Forey; Monique Reyrolle; Pascale Girardo; Pierre Farge; Bénédicte Decludt; Christine Campese; François Vandenesch; Sophie Jarraud
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

Review 5.  Legionella and Legionnaires' disease: 25 years of investigation.

Authors:  Barry S Fields; Robert F Benson; Richard E Besser
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

6.  High Prevalence and Genetic Polymorphisms of Legionella in Natural and Man-Made Aquatic Environments in Wenzhou, China.

Authors:  Leyi Zhang; Yi Li; Xin Wang; Zhihui Shangguan; Haijian Zhou; Yuejin Wu; Lianghuai Wang; Hongyu Ren; Yun Hu; Meifen Lin; Tian Qin
Journal:  Int J Environ Res Public Health       Date:  2017-02-24       Impact factor: 3.390

7.  Evaluation of an Optimal Epidemiological Typing Scheme for Legionella pneumophila with Whole-Genome Sequence Data Using Validation Guidelines.

Authors:  Sophia David; Massimo Mentasti; Rediat Tewolde; Martin Aslett; Simon R Harris; Baharak Afshar; Anthony Underwood; Norman K Fry; Julian Parkhill; Timothy G Harrison
Journal:  J Clin Microbiol       Date:  2016-06-08       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.